Search | Invivogen

Human IL-3Rα (CD123) Antibody - Talacotuzumab Biosimilar

Human IgG1 (S239D/I332E) - CAS #1826831-79-1

Neutralization of human IL-3 signaling using Talacotuzumab

Human BCMA x E. coli β-Gal Bispecific Antibody - Negative Control

Control scFv antibody - Recombinant

Evaluation of T cell activation

Absence of Jurkat-Lucia™ NFAT cell activation using Anti-hBCMA-βgal

Human EpCAM x E. coli β-Gal Bispecific Antibody - Negative Control

Control scFv antibody - Recombinant

Evaluation of T cell activation (ELISA)

Absence of Jurkat-Lucia™ NFAT cell activation using Anti-hEpCAM-βgal

Human EpCAM x Human CD3 Bispecific Antibody

Solitomab scFv antibody - Recombinant

Evaluation of T cell activation (ELISA)

Human BCMA x Human CD3 Bispecific Antibody

Pacanalotamab scFv antibody - Recombinant

Evaluation of T cell activation

E. coli β-Gal x Human CD3 Bispecific Antibody - Negative Control

Control scFv antibody - Recombinant

Activation of Jurkat-Lucia™ NFAT cells with Anti-hCD19-CD3

Anti-βgal-hCD3 does not allow Jurkat-Lucia™ NFAT cell activation

Human CD19 x E. coli β-Gal Bispecific Antibody - Negative control

Control scFv antibody - Recombinant

Activation of Jurkat-Lucia™ NFAT cells with Anti-hCD19-CD3

Absence of Jurkat-Lucia™ NFAT cell activation using Anti-βgal-hCD3

Human CD19 x Human CD3 Bispecific Antibody

Blinatumomab scFv antibody - Recombinant

Evaluation of T cell activation

Target specificity of Anti-hCD19-CD3

Jurkat-Lucia™ NFAT cell activation

Activation of Jurkat-Lucia™ NFAT cells with Anti-hCD19-CD3